Cargando…
Targeting Certain Interleukins as Novel Treatment Options for Liver Fibrosis
The liver is a major metabolic organ and an immunologically complex organ. It produces and uses many substances such as acute phase proteins, cytokines, chemokines, and complementary components to maintain the balance between immunity and tolerance. Interleukins are important immune control cytokine...
Autores principales: | An, Su Yeon, Petrescu, Anca D., DeMorrow, Sharon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024568/ https://www.ncbi.nlm.nih.gov/pubmed/33841164 http://dx.doi.org/10.3389/fphar.2021.645703 |
Ejemplares similares
-
Interleukin-24 therapy- a potential new strategy against liver fibrosis
por: Petrescu, Anca D., et al.
Publicado: (2021) -
Farnesoid X Receptor as Target for Therapies to Treat Cholestasis-Induced Liver Injury
por: Petrescu, Anca D., et al.
Publicado: (2021) -
Hypothalamus-Pituitary-Adrenal Dysfunction in Cholestatic Liver Disease
por: Petrescu, Anca D., et al.
Publicado: (2018) -
Glucocorticoids Cause Gender-Dependent Reversal of Hepatic Fibrosis in the MDR2-Knockout Mouse Model
por: Petrescu, Anca D., et al.
Publicado: (2017) -
Ghrelin reverses ductular reaction and hepatic fibrosis in a rodent model of cholestasis
por: Petrescu, Anca D., et al.
Publicado: (2020)